# OnCo record vittoria-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/vittoria-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "vittoria-biotherapeutics" ;
  schema:name "Vittoria Biotherapeutics"@en ;
  schema:alternateName "viTToria Biotherapeutics"@en ;
  schema:description "Vittoria Biotherapeutics makes CAR-T cell therapy, a patient's own immune cells engineered to attack cancer, for T-cell lymphoma, a cancer of the same kind of cell that CAR-T is made from. Its first product, VIPER-101, is in an early trial."@en ;
  schema:url <https://onco.cc/companies/vittoria-biotherapeutics/>, <https://www.vittoriabio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.vittoriabio.com/>, <https://vittoriabio.com/pipeline/>, <https://clinicaltrials.gov/study/NCT06420089> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> .